Cargando…
Guidance for Administering Biologics for Severe Asthma and Allergic Conditions
Asthma is a common respiratory disorder in Canada for which biologics may be prescribed for poorly controlled illness. Treatment with biologics, however, is sometimes inappropriately discontinued due to misconceptions regarding their potential immunologic effects, and concerns surrounding their cont...
Autores principales: | Dorscheid, Delbert R., Lee, Jason K., Ramesh, Warren, Greenwald, Mark, Del Carpio, Jaime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482537/ https://www.ncbi.nlm.nih.gov/pubmed/36124286 http://dx.doi.org/10.1155/2022/9355606 |
Ejemplares similares
-
Omalizumab in patients with severe asthma and persistent sputum eosinophilia
por: Mukherjee, Manali, et al.
Publicado: (2019) -
Hedgehog Signaling as a Therapeutic Target for Airway Remodeling and Inflammation in Allergic Asthma
por: Tam, Anthony, et al.
Publicado: (2022) -
Understanding the roles of the transcription factors nuclear factor-κB and hypoxia-inducible factor-1α in lung injury
por: Craig, Katherine, et al.
Publicado: (2002) -
Introducing Critical Care's ongoing reviews of science
por: Dorscheid, Delbert R, et al.
Publicado: (2002) -
Omalizumab for Severe Asthma: Beyond Allergic Asthma
por: Loureiro, C. C., et al.
Publicado: (2018)